Gelatin-based composite hydrogels with biomimetic lubrication and sustained drug release

Kuan Zhang,Jielai Yang,Yulong Sun,Yi Wang,Jing Liang,Jing Luo,Wenguo Cui,Lianfu Deng,Xiangyang Xu,Bo Wang,Hongyu Zhang
DOI: https://doi.org/10.1007/s40544-020-0437-5
IF: 4.924
2021-01-11
Friction
Abstract:Abstract The occurrence of osteoarthritis is closely related to progressive and irreversible destruction of the articular cartilage, which increases the friction significantly and causes further inflammation of the joint. Thus, a scaffold for articular cartilage defects should be developed via lubrication restoration and drug intervention. In this study, we successfully synthesized gelatin-based composite hydrogels, namely GelMA-PAM-PMPC, with the properties of biomimetic lubrication and sustained drug release by photopolymerization of methacrylic anhydride modified gelatin (GelMA), acrylamide (AM), and 2-methacryloyloxyethyl phosphorylcholine (MPC). Tribological test showed that the composite hydrogels remarkably enhanced lubrication due to the hydration lubrication mechanism, where a tenacious hydration shell was formed around the zwitterionic phosphocholine headgroups. In addition, drug release test indicated that the composite hydrogels efficiently encapsulated an anti-inflammatory drug (diclofenac sodium) and achieved sustained release. Furthermore, the in vitro test revealed that the composite hydrogels were biocompatible, and the mRNA expression of both anabolic and catabolic genes of the articular cartilage was suitably regulated. This indicated that the composite hydrogels could effectively protect chondrocytes from inflammatory cytokine-induced degeneration. In summary, the composite hydrogels that provide biomimetic hydration lubrication and sustained local drug release represent a promising scaffold for cartilage defects in the treatment of osteoarthritis.
engineering, mechanical
What problem does this paper attempt to address?
The problems that this paper attempts to solve are two key challenges in arthritis treatment: insufficient restoration of lubrication at the articular cartilage defect and poor persistence of drug intervention. Specifically, the occurrence of arthritis is closely related to the progressive and irreversible destruction of articular cartilage, which leads to a significant increase in joint friction and triggers further inflammatory reactions. Therefore, it is necessary to develop a scaffold material that can simultaneously restore lubrication and achieve drug intervention in order to effectively treat arthritis. For this purpose, the research team designed and synthesized a gelatin - based composite hydrogel (GelMA - PAM - PMPC). This hydrogel has the dual functions of bionic lubrication and continuous drug release. Through photopolymerization reaction, gelatin modified with methacrylic anhydride (GelMA), acrylamide (AM) and 2 - methacryloyloxyethyl phosphorylcholine (MPC) were combined together to prepare this composite hydrogel. The research results show that this composite hydrogel not only significantly improves the lubrication performance, but also can efficiently encapsulate and continuously release anti - inflammatory drugs (such as diclofenac sodium), and shows good biocompatibility and protective effect on articular chondrocytes in vitro tests. In conclusion, this study aims to provide a new strategy for the treatment of articular cartilage defects by developing a composite hydrogel with bionic lubrication and continuous drug release functions, especially showing great application potential in the treatment of arthritis.